Lurasidone +pharma

Leaflet accompanying the packaging: patient information

Lurasidone +pharma, 18.5 mg, coated tablets

Lurasidone +pharma, 37 mg, coated tablets

Lurasidone +pharma, 74 mg, coated tablets

Lurasidone

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

• Keep this leaflet, you may need to read it again.
• In case of any doubts, consult a doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including those not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of contents of the leaflet

• 1. What is Lurasidone +pharma and what is it used for
• 2. Important information before taking Lurasidone +pharma
• 3. How to take Lurasidone +pharma
• 4. Possible side effects
• 5. How to store Lurasidone +pharma
• 6. Contents of the packaging and other information

1. What is Lurasidone +pharma and what is it used for

Lurasidone +pharma contains the active substance lurasidone, which belongs to a group of medicines called antipsychotics. It is used to treat symptoms of schizophrenia in adult patients (18 years and older) and adolescents aged 13-17 years. Lurasidone works by blocking receptors in the brain that dopamine and serotonin bind to. Dopamine and serotonin are neurotransmitters (substances that enable nerve cells to communicate with each other) associated with the occurrence of schizophrenia symptoms. By blocking these receptors, lurasidone helps to normalize brain activity, reducing schizophrenia symptoms.
Schizophrenia is a disorder characterized by symptoms such as hearing, seeing, or feeling non-existent things, false beliefs, unusual suspiciousness, withdrawal, incoherent speech, and flattening of behaviors and emotions. People with this disorder may also experience depression, anxiety, guilt, or tension. This medicine is used to alleviate schizophrenia symptoms.

2. Important information before taking Lurasidone +pharma

When not to take Lurasidone +pharma

• if the patient is allergic to lurasidone or any of the other ingredients of this medicine (listed in section 6)
• if the patient is taking medicines that may affect the level of lurasidone in the blood, namely:
• medicines used to treat fungal infections, such as itraconazole, ketoconazole (except ketoconazole in shampoo), posaconazole, or voriconazole
• medicines used to treat infections, such as the antibiotic clarithromycin or telithromycin
• medicines used to treat HIV infection, such as cobicistat, indinavir, nelfinavir, ritonavir, and saquinavir
• medicines for chronic hepatitis, such as boceprevir and telaprevir
• an antidepressant - nefazodone
• a medicine for tuberculosis - rifampicin
• medicines used to treat epilepsy, such as carbamazepine, phenobarbital, and phenytoin
• herbal products used to treat depression - St. John's Wort (Hypericum perforatum).

Warnings and precautions

It may take several days or even weeks for this medicine to start working fully. If you have any questions about this medicine, consult your doctor.
Before starting to take Lurasidone +pharma or during treatment, discuss this with your doctor, especially if:

• the patient has suicidal thoughts or exhibits suicidal behavior
• the patient has Parkinson's disease or dementia
• the patient has been diagnosed with a condition characterized by high fever and muscle stiffness (called malignant neuroleptic syndrome) or has experienced muscle stiffness and tremors or had problems with movement (extrapyramidal symptoms) or abnormal movements of the tongue or face (tardive dyskinesia). Note that this medicine may cause such symptoms.
• the patient has heart disease or is taking medicines for heart disease that may cause low blood pressure or has a family history of heart rhythm disorders (including QT prolongation)
• the patient has had seizures or epilepsy
• the patient or a family member has had blood clots, as antipsychotic medicines are associated with the formation of blood clots
• the patient has enlarged breasts (in men, gynecomastia), milk secretion from the breasts (galactorrhea), absence of menstruation, or erectile dysfunction
• the patient has diabetes or is prone to diabetes
• the patient has impaired kidney function
• the patient has impaired liver function
• the patient's weight has increased
• the patient experiences a drop in blood pressure when standing up, which may cause fainting
• the patient is addicted to opioids (treated with buprenorphine), has severe pain (treated with opioids), or depression, or other conditions treated with antidepressants. Taking these medicines with Lurasidone +pharma may lead to the occurrence of serotonin syndrome, a potentially life-threatening condition (see "Lurasidone +pharma and other medicines").

If the patient is affected by any of the above conditions, they should tell their doctor, who may decide to change the dose of the medicine, monitor the patient's condition more closely, or stop taking Lurasidone +pharma.

Children and adolescents

This medicine should not be given to children under 13 years of age.

Lurasidone +pharma and other medicines

Tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take.
This is especially important if you are taking:

• any medicines that affect the brain, as they may negatively affect the action of Lurasidone +pharma on the brain
• medicines that lower blood pressure, as this medicine may also lower blood pressure
• medicines for Parkinson's disease and restless legs syndrome (e.g., levodopa), as this medicine may weaken their effect
• medicines containing ergot alkaloid derivatives (used to treat migraines) and other medicines, including terfenadine and astemizole (used to treat hay fever and other allergic symptoms), cisapride (used to treat digestive problems), pimozide (used to treat mental illnesses), quinidine (used to treat heart conditions), and bepridil (used to treat chest pain)
• medicines containing buprenorphine (used to treat opioid addiction) or opioids (used to treat severe pain), or antidepressants, such as moclobemide, tranylcypromine, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, amitriptyline, doxepin, or trimipramine. These medicines may interact with Lurasidone +pharma and may cause symptoms such as involuntary, rhythmic muscle contractions, excitement, hallucinations, coma, excessive sweating, tremors, exaggerated reflexes, increased muscle tension, and body temperature above 38°C. If such symptoms occur, consult a doctor.

If you are taking any of these medicines, tell your doctor, who may decide to change the dose of such a medicine during treatment with Lurasidone +pharma.
The following medicines may increase the level of lurasidone in the blood:

• diltiazem (used to treat high blood pressure)
• erythromycin (an antibiotic used to treat infections)
• fluconazole (used to treat fungal infections)
• verapamil (used to treat high blood pressure or chest pain)

The following medicines may decrease the level of lurasidone in the blood:

• amprenavir, efavirenz, etravirine (used to treat HIV infection)
• aprepitant (used to treat nausea and vomiting)
• armodafinil, modafinil (used to treat sleepiness)
• bosentan (used to treat high blood pressure or finger ulcers)
• nafcillin (used to treat infections)
• prednisone (used to treat inflammatory diseases)
• rufinamide (used to treat epilepsy)

If you are taking any of these medicines, tell your doctor, who may decide to change the dose of Lurasidone +pharma.

Taking Lurasidone +pharma with food, drink, and alcohol

While taking this medicine, avoid drinking alcohol, as it may enhance the negative effects of the medicine.
While taking this medicine, do not drink grapefruit juice. Grapefruit may affect the action of this medicine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Do not take this medicine during pregnancy unless your doctor has decided that it is necessary.
If your doctor decides that the potential benefits of treatment during pregnancy outweigh the potential risks to the unborn child, they will closely monitor the child's condition after birth.
This is because newborns whose mothers took lurasidone during the last trimester of pregnancy (the last 3 months) may experience symptoms such as:

• tremors, stiffness, and/or muscle relaxation, sleepiness, excitement, breathing problems, and feeding difficulties

If the child experiences any of these symptoms, consult a doctor.
It is not known whether lurasidone passes into breast milk. If you are breastfeeding or plan to breastfeed, discuss this with your doctor.

Driving and using machines

During treatment with this medicine, drowsiness, dizziness, or vision disturbances may occur (see section 4 "Possible side effects"). Do not drive vehicles, ride a bike, or operate any tools or machines until you know that this medicine does not affect you negatively.

Lurasidone +pharma contains sodium

The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".

3. How to take Lurasidone +pharma

Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, consult your doctor or pharmacist.
Your doctor will determine the dose for your specific condition, taking into account:

• the patient's response to the prescribed dose
• any other medicines the patient is taking (see section 2 "Lurasidone +pharma and other medicines")
• any kidney or liver problems the patient may have

Adults (18 years and older)

The recommended starting dose is 37 mg once a day.
Your doctor may increase or decrease this dose within the range of 18.5 mg to 148 mg once a day.
The maximum dose should not exceed 148 mg once a day.

Adolescents (13-17 years)

The recommended starting dose is 37 mg of lurasidone once a day.
The dose may be increased or decreased by your doctor within the range of 37 to 74 mg once a day.
The maximum daily dose should not exceed 74 mg.

How to take Lurasidone +pharma

Swallow the tablet(s) whole with water to avoid the bitter taste.
Take your dose of the medicine regularly, every day at the same time, which will help you remember to take the medicine. This medicine should be taken with food or immediately after a meal, which will help the body absorb the medicine and allow it to work better.

Taking a higher dose of Lurasidone +pharma than recommended

If you take a higher dose of Lurasidone +pharma than recommended, contact your doctor immediately. You may experience drowsiness, fatigue, abnormal body movements, problems standing and walking, dizziness due to low blood pressure, and abnormal heart rhythm.

Missing a dose of Lurasidone +pharma

Do not take a double dose to make up for a missed dose. If you miss one dose of the medicine, take the next dose the following day. If you miss two or more doses, consult your doctor.

Stopping treatment with Lurasidone +pharma

If you stop taking this medicine, you will lose its effects. Do not stop taking this medicine unless your doctor tells you to, as your symptoms may return.
If you have any further questions about taking this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Seek medical help immediately if you experience any of the following symptoms:

• severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, itching, rash, and sometimes a drop in blood pressure (hypersensitivity). Such reactions are common (may occur in up to 1 in 10 patients).
• severe rash with blisters on the skin, in the mouth, eyes, and genitals (Stevens-Johnson syndrome). This reaction occurs with an unknown frequency.
• fever, sweating, muscle stiffness, and impaired consciousness. These may be symptoms of a condition called malignant neuroleptic syndrome. These reactions are rare (may occur in up to 1 in 1000 patients).
• blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the legs), which can travel through the bloodstream to the lungs, causing chest pain and difficulty breathing. If you experience any of these symptoms, seek medical help immediately.

Adults may also experience the following side effects:
Very common(may occur in more than 1 in 10 patients)

• feeling restless and unable to sit still
• nausea (feeling sick)
• insomnia

Common(may occur in up to 1 in 10 patients)

• Parkinsonism: a general medical term that includes many symptoms, such as increased saliva production or wet mouth, drooling, muscle tremors when bending limbs, slow, limited, or impaired body movements, lack of facial expression, muscle tension, neck stiffness, muscle stiffness, walking with small, quick steps and dragging feet, and lack of normal arm movements when walking, persistent eye blinking in response to tapping on the forehead (abnormal reflexes)
• speech disorders, abnormal muscle movements, a syndrome of symptoms called extrapyramidal symptoms (EPS), which include abnormal, purposeless, involuntary muscle movements
• rapid heartbeat
• high blood pressure
• dizziness
• muscle cramps and stiffness
• vomiting
• diarrhea
• back pain
• rash and itching
• indigestion
• dry mouth or excessive salivation
• abdominal pain
• drowsiness, fatigue, excitement, and anxiety
• weight gain
• increased activity of the enzyme creatine phosphokinase (found in muscles) shown in blood tests
• increased creatinine level (a marker of kidney function) shown in blood tests
• decreased appetite

Uncommon(may occur in up to 1 in 100 patients)

• slurred speech
• nightmares
• difficulty swallowing
• irritation of the stomach lining
• sudden feeling of anxiety
• seizures (fits)
• chest pain
• muscle pain
• temporary loss of consciousness
• feeling of spinning
• disorders of electrical impulse conduction in the heart
• slow heart rate
• joint pain
• walking difficulties
• stiffened body posture
• increased prolactin level in the blood, increased glucose level in the blood (blood sugar), increased activity of certain liver enzymes (shown in blood tests)
• high blood pressure
• drop in blood pressure when standing up, which may cause fainting
• common cold
• hot flashes
• blurred vision
• sweating
• pain when urinating
• uncontrolled movements of the mouth, tongue, and limbs (tardive dyskinesia)
• low sodium level in the blood, which may cause fatigue and disorientation, muscle tremors, seizures, and coma (hyponatremia)
• lack of energy (lethargy)
• gas in the intestines
• neck pain
• erectile dysfunction
• painful menstrual bleeding or absence of menstruation
• decreased number of red blood cells (which distribute oxygen in the body)

Rare(may occur in up to 1 in 1000 patients)

• rhabdomyolysis, a breakdown of muscle fibers that releases muscle contents into the bloodstream, characterized by muscle pain, nausea, feeling confused, abnormal heart rhythm, and possibly dark urine
• increased number of eosinophils (a type of white blood cell)
• swelling under the skin surface (angioedema)
• intentional self-harm
• stroke or cerebral vascular event
• kidney failure
• decreased number of white blood cells (which fight infections)
• chest pain, milk secretion from the breasts
• sudden death

Frequency not known(frequency cannot be estimated from available data)

• decreased number of neutrophils (a type of white blood cell)
• sleep disorders
• in newborns, symptoms such as excitement, increased or decreased muscle tone, tremors, sleepiness, breathing problems, or feeding difficulties may be observed
• abnormal breast enlargement
• in the elderly with dementia, a small increase in the number of deaths has been observed in patients taking antipsychotic medicines compared to those not taking these medicines

Adolescents may experience the following side effects:
Very common(may occur in more than 1 in 10 patients)

• feeling restless and unable to sit still
• headache
• drowsiness
• nausea (feeling sick)

Common(may occur in up to 1 in 10 patients)

• increased or decreased appetite
• abnormal dreams
• difficulty sleeping, tension, excitement, anxiety, and irritability
• physical weakness, fatigue
• depression
• psychotic disorders: a medical term referring to many mental illnesses that cause disturbances in thinking and perception; patients with psychoses lose contact with reality
• schizophrenia symptoms
• difficulty concentrating
• feeling of spinning
• abnormal, involuntary movements (dyskinesia)
• abnormal muscle tension, including neck stiffness and involuntary eye movements
• Parkinsonism: a general medical term that includes many symptoms, such as increased saliva production or wet mouth, drooling, muscle tremors when bending limbs, slow, limited, or impaired body movements, lack of facial expression, muscle tension, neck stiffness, muscle stiffness, walking with small, quick steps and dragging feet, and lack of normal arm movements when walking, persistent eye blinking in response to tapping on the forehead (abnormal reflexes)
• rapid heartbeat
• difficulty urinating (constipation)
• dry mouth or excessive salivation
• vomiting
• sweating
• muscle stiffness
• erectile dysfunction
• increased creatine phosphokinase level in the blood (a muscle enzyme), increased prolactin level in the blood
• weight gain or loss

Uncommon(may occur in up to 1 in 100 patients)

• hypersensitivity
• common cold, throat infection
• increased thyroid activity, thyroid inflammation
• aggressive behavior, impulsive behavior
• apathy
• confusion
• depressed mood
• loss of contact with normal thought processes (dissociative disorders)
• hallucinations (hearing or seeing things)
• thoughts of murder
• difficulty sleeping
• increased or decreased sexual desire
• lack of energy
• changes in mental state
• obsessive thoughts
• feeling of intense and overwhelming anxiety (panic attack)
• performing involuntary, purposeless movements (psychomotor agitation)
• muscle overactivity (hyperkinesia), inability to rest (restlessness)
• uncontrolled urge to move the legs (restless legs syndrome), uncontrolled movements of the mouth, tongue, and limbs (tardive dyskinesia)
• sleep disorders
• suicidal thoughts
• thought disorders
• instability (feeling of spinning)
• changes in taste perception
• memory disorders
• abnormal sensations on the skin (paresthesia)
• feeling of wearing a tight band around the head (tension headache), migraines
• difficulty focusing, blurred vision
• increased sensitivity to sound
• palpitations, changes in heart rhythm
• drop in blood pressure when standing up, which may cause fainting
• high blood pressure
• abdominal pain or discomfort
• lack of saliva or excessive salivation
• diarrhea
• indigestion
• dry lips
• toothache
• partial or complete hair loss, abnormal hair growth
• rash, hives
• muscle cramps and stiffness, muscle pain
• joint pain, arm and leg pain, jaw pain
• presence of bilirubin in the urine, presence of protein in the urine - a marker of kidney function
• pain or difficulty urinating, frequent urination, kidney function disorders
• sexual function disorders
• difficulty ejaculating
• abnormal breast enlargement, breast pain, milk secretion from the breasts
• irregular menstrual cycles or absence of menstruation
• making uncontrolled sounds and movements (Tourette's syndrome)
• chills
• walking difficulties
• feeling unwell
• chest pain
• fever
• intentional overdose
• effect on thyroid function, shown in blood tests: increased cholesterol level, increased triglyceride level, decreased HDL level, decreased LDL level
• increased glucose level in the blood (blood sugar), increased insulin level in the blood, increased activity of certain liver enzymes (a marker of liver function) - shown in blood tests
• increased or decreased testosterone level in the blood, increased TSH level - shown in blood tests
• changes in ECG
• decreased hemoglobin level, decreased number of white blood cells (which fight infections)
• shown in blood tests.

Reporting side effects

If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder or its representative in Poland.
Reporting side effects will help gather more information on the safety of this medicine.

5. How to store Lurasidone +pharma

Keep the medicine out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after "EXP:". The expiry date refers to the last day of the month.
There are no special storage instructions for this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the packaging and other information

What Lurasidone +pharma contains

• The active substance of the medicine is lurasidone.

Lurasidone +pharma, 18.5 mg, coated tablets
Each coated tablet contains lurasidone hydrochloride equivalent to 18.6 mg of lurasidone.
Lurasidone +pharma, 37 mg, coated tablets
Each coated tablet contains lurasidone hydrochloride equivalent to 37.2 mg of lurasidone.
Lurasidone +pharma, 74 mg, coated tablets
Each coated tablet contains lurasidone hydrochloride equivalent to 74.5 mg of lurasidone.

• Other ingredients are: tablet core: mannitol, cornstarch, microcrystalline cellulose, sodium carboxymethylcellulose, hypromellose type 2910, colloidal anhydrous silica, magnesium stearate

tablet coating (Lurasidone +pharma, 18.5 mg and 37 mg, coated tablets): hypromellose type 2910, titanium dioxide (E 171), macrogol, carnauba wax
tablet coating (Lurasidone +pharma, 74 mg, coated tablets): hypromellose type 2910, titanium dioxide (E 171), macrogol, yellow iron oxide (E 172), indigo carmine (E 132), carnauba wax

What Lurasidone +pharma looks like and contents of the pack

Lurasidone +pharma, 18.5 mg, coated tablets
White or almost white, round, biconvex coated tablets with a diameter of 6 mm, with the letter "L" embossed on one side and smooth on the other.
Lurasidone +pharma, 37 mg, coated tablets
White or almost white, round, biconvex coated tablets with a diameter of 8 mm, with the letter "I" embossed on one side and smooth on the other.
Lurasidone +pharma, 74 mg, coated tablets
Light green to green, oval, biconvex coated tablets with dimensions of 12 x 7 mm, with the letter "I" embossed on one side and smooth on the other.
Lurasidone +pharma coated tablets are available in packs containing 28 coated tablets in aluminum/aluminum blisters.

Marketing authorization holder

+pharma arzneimittel gmbh
Hafnerstrasse 211
8054 Graz
Austria

Manufacturer

LABORATORIOS LICONSA, S.A.
Avda. Miralcampo, 7
Pol. Ind. Miralcampo
19200 Azuqueca De Henares (Guadalajara)
Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Austria
Lurasidon Genericon 18.5 mg/37 mg/74 mg Filmtabletten
Czech Republic
Lurasidone +pharma
Poland
Lurasidone +pharm
Sweden
Lurasidone Genericon
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
+pharma Polska sp. z o.o.
ul. Podgórska 34
31-536 Kraków, Poland
tel.: +48 12 262 32 36
e-mail: krakow@pluspharma.eu

Date of last revision of the leaflet: